Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vir Biotechnology, Inc. (VIR)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 127,390,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. Co.'s existing pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus, influenza A virus, and human immunodeficiency virus. Co. has collaborate with Glaxo Wellcome UK Limited and GlaxoSmithKline Biologicals S.A. to focus on treating and preventing severe acute respiratory syndrome coronavirus 2 (the virus that causes COVID-19 illness). Co. is developing differentiated monoclonal antibodies, like sotrovimab and VIR-7832, as well as vaccines and small molecules.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,186,607 2,244,189 2,401,884 2,593,620
Total Sell Value $13,000,321 $13,295,167 $14,541,281 $16,428,809
Total People Sold 4 6 10 13
Total Sell Transactions 22 27 38 53
End Date 2025-08-24 2025-05-23 2024-11-22 2023-11-23

   
Records found: 653
  Page 1 of 27  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Obyrne Jason EVP & Chief Financial Officer   •       –      –    2025-11-17 4 S $5.56 $37,782 D/D (6,799) 110,701     -
   De Verneuil Vanina EVP, General Counsel, Corp Sec   •       –      –    2025-11-05 4 AS $5.16 $12,307 D/D (2,385) 78,210     -
   De Verneuil Vanina EVP and General Counsel   •       –      –    2025-11-03 4 S $5.86 $8,003 D/D (1,365) 80,595     -
   Sato Vicki L Director   –       •      –    2025-11-03 4 AS $5.64 $124,047 D/D (22,000) 1,210,391     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-29 4 AS $6.49 $649 I/I (100) 14,573,983     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-28 4 AS $6.50 $159,006 I/I (24,453) 14,574,083     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-27 4 AS $6.05 $401,585 I/I (66,403) 14,598,536     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-24 4 AS $5.96 $278,285 I/I (46,696) 14,664,939     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-23 4 AS $5.99 $924,723 I/I (154,383) 14,711,635     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-22 4 AS $6.15 $887,654 I/I (144,266) 14,866,018     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-21 4 AS $6.30 $690,974 I/I (109,675) 15,010,284     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-20 4 AS $6.20 $1,367,273 I/I (220,535) 15,119,959     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-16 4 AS $6.10 $78,366 I/I (12,844) 15,340,494     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-15 4 AS $6.07 $101,196 I/I (16,671) 15,353,338     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-10 4 AS $6.08 $13,973 I/I (2,300) 15,370,009     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-09 4 AS $6.14 $1,529,926 I/I (249,060) 15,372,309     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-08 4 AS $6.05 $2,819,785 I/I (466,242) 15,621,369     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-07 4 AS $5.60 $404,154 I/I (72,133) 16,087,611     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-06 4 AS $5.69 $420,641 I/I (73,955) 16,159,744     -
   Sb Investment Advisers (uk) Ltd 10% Owner   –       –       •   2025-10-03 4 AS $5.56 $2,501,785 I/I (450,342) 16,233,699     -
   Sato Vicki L Director   –       •      –    2025-10-01 4 AS $5.84 $128,396 D/D (22,000) 1,232,391     -
   Sato Vicki L Director   –       •      –    2025-09-02 4 AS $4.99 $109,811 D/D (22,000) 1,254,391     -
   Sato Vicki L Director   –       •      –    2025-08-01 4 AS $4.99 $109,699 D/D (22,000) 1,276,391     -
   Eisner Mark EVP and Chief Medical Officer   •       –      –    2025-07-17 4 AS $5.47 $19,629 D/D (3,586) 104,618     -
   Eisner Mark EVP and Chief Medical Officer   •       –      –    2025-07-15 4 AS $5.47 $37,162 D/D (6,796) 108,204     -
  653 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 27
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us